Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

Nature Medicine volume 2, pages 1367–1370 (1996)Cite this article

Abstract

Given the plethora of well–documented breast carcinoma–associated antigens in humans including MAGE–1, –2 and –3, mutated p53, p21ras, HER–2/neu and DF3/MUC–1, coupled with evidence that humoral and cytotoxic T–cell responses against these antigens exist1–6, the central dilemma facing tumor immunologists is why the host immune response is so inefficient. One possibility is that tumor cells themselves are either inefficient or ineffective antigen–presenting cells (APCs). The failure of tumor cells to function as APCs may be due to their inability to process and present the antigen, the absence or insufficient numbers of adhesion and costimulatory molecules or, potentially, the secretion of inhibitory cytokines. Therefore, we sought to determine whether human breast cancer cell lines could function as APCs and, if not, to identify mechanism(s) responsible for this defect. Here, we show that human breast cancer cell lines fail to present alloantigen. This defect does not reside in their inherent capacity to present antigen but rather is due to apoptosis of activated T cells induced by exposure to the breast carcinoma–associated mucin antigen, DF3/MUC1. These results support the hypothesis that DF3/MUC1 may contribute to the paucity of clinically significant anticarcinoma–specific immune responses.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. van de Bruggen, P. et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254, 1643–1647 (1991).

    Article  Google Scholar 

  2. Schlichtholz, B., Legros, Y. & Gillet, D. The immune response to p53 in breast can cer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res. 52, 6380–6384 (1992).

    CAS  Google Scholar 

  3. Jung, V. et al. Expression and reconstitution of a biologically active human inter-feron-gamma receptor in hamster cells. J. Biol Chem. 265, 1827–1830 (1990).

    CAS  PubMed  Google Scholar 

  4. Disis, M.L. et al Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res. 54, 16–20 (1994).

    CAS  PubMed  Google Scholar 

  5. Barnd, D.L., Lan, M.S., Metzgar, R.S. & Finn, O.J. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl Acad. Scl USA 86, 7159–7163 (1989).

    Article  CAS  Google Scholar 

  6. Jerome, K.R. et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res. 51, 2908–2916 (1991).

    CAS  Google Scholar 

  7. Gendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J. & Burchell, J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol. Chem. 263, 12820–12823 (1988).

    CAS  PubMed  Google Scholar 

  8. Siddiqui, J. et al. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc. Natl. Acad. Sci. USA 85, 2320–2323 (1988).

    Article  CAS  Google Scholar 

  9. Wesseling, J., van der Valk, S. & Hilkens, J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol. Biol. Cell 7, 565–577 (1996).

    Article  CAS  Google Scholar 

  10. Ligtenberg, M., Buijs, F., Vos, H. & Hilkens, J. Suppression of cellular aggregation by high levels of episialin. Cancer Res. 52, 2318–2324 (1992).

    CAS  PubMed  Google Scholar 

  11. van de Wiel-van Kemenade, E. et al. Episialin (MUC1) inhibits cytotoxic lympho cyte-target cell interaction. J lmmunol. 151, 767–776 (1993).

    CAS  Google Scholar 

  12. Girling, A. et al A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer 43, 1072–1076 (1989).

    Article  CAS  Google Scholar 

  13. Hull, S. et al Oligosaccharide differences in the DF3 sialomucin antigen from nor mal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun. 1, 261–267 (1989).

    CAS  PubMed  Google Scholar 

  14. Kotera, Y., Fontenot, J.D., Pecher, G., Metzgar, R.S. & Finn, O.J. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res. 54, 2856–2860 (1994).

    CAS  Google Scholar 

  15. McKolanis, J., Pecher, G., Lotze, M. & Finn, O. Mucin reactive CTL induced by in vivo immunization [Abstr.]. Proc. Am. Assoc. Cancer Res. 87, 3144 (1996).

    Google Scholar 

  16. Boussiotis, V.A., Freeman, G.J., Gray, G.S., Gribben, J.G. & Nadler, L.M. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J. Exp. Med. 178, 1753–1763 (1993).

    Article  CAS  Google Scholar 

  17. Dranoff, G. et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539–3543 (1993).

    Article  CAS  Google Scholar 

  18. Gimmi, C.D. et al. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88, 6575–6579 (1991).

    Article  CAS  Google Scholar 

  19. Hayes, D.F., Silberstein, D.S., Rodrigue, S. & Kufe, D.W. DF3 antigen, a human epithelial cell mucin, inhibits adhesion of eosinophils to antibody-coated targets. J. Immunol. 145, 962–970 (1990).

    CAS  PubMed  Google Scholar 

  20. Kufe, D.W. et al Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3, 223–232 (1984).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division ofHematologic Malignancies, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts, 02115, USA

    Claude D. Gimmi, Briggs W. Morrison, Brigitte A. Mainprice, John G. Gribben, Vassiliki A. Boussiotis, Gordon J. Freeman, Suun Young Lee Park & Lee M. Nadler

  2. Department of Medicine, Harvard Medical School, 25 Shattuck Street, Boston, Massachusetts, 02115, USA

    Claude D. Gimmi, Briggs W. Morrison, Brigitte A. Mainprice, John G. Gribben, Vassiliki A. Boussiotis, Gordon J. Freeman, Suun Young Lee Park & Lee M. Nadler

  3. Division of Cancer Pharmacology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts, 02115, USA

    Michiaki Watanabe, JianLin Gong, Daniel F. Hayes & Donald W. Kufe

  4. Department of Medicine, Harvard Medical School, 25 Shattuck Street, Boston, Massachusetts, 02115, USA

    Michiaki Watanabe, JianLin Gong, Daniel F. Hayes & Donald W. Kufe

Authors
  1. Claude D. Gimmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Briggs W. Morrison
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brigitte A. Mainprice
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John G. Gribben
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vassiliki A. Boussiotis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gordon J. Freeman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Suun Young Lee Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michiaki Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. JianLin Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Daniel F. Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Donald W. Kufe
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Lee M. Nadler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gimmi, C., Morrison, B., Mainprice, B. et al. Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nat Med 2, 1367–1370 (1996). https://doi.org/10.1038/nm1296-1367

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1296-1367

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing